Ditchcarbon
  • Contact
  1. Organizations
  2. Guardant Health
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 15 days ago

Guardant Health

Company website

Guardant Health, Inc., a leading precision oncology company, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2012, the company has rapidly established itself in the biotechnology industry, focusing on non-invasive cancer detection and monitoring through advanced genomic testing. Guardant Health is renowned for its flagship product, the Guardant360® test, which provides comprehensive genomic profiling of solid tumours using a simple blood draw. This innovative approach allows for personalised treatment strategies, setting the company apart in the competitive landscape of cancer diagnostics. With a strong market position, Guardant Health has achieved notable milestones, including partnerships with major pharmaceutical companies and contributions to pivotal clinical trials. Its commitment to transforming cancer care through cutting-edge technology continues to drive its success in the oncology sector.

DitchCarbon Score

How does Guardant Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Guardant Health's score of 32 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

54%

Let us know if this data was useful to you

Guardant Health's reported carbon emissions

In 2023, Guardant Health, headquartered in the United States, reported total carbon emissions of approximately 4,222,000 kg CO2e. This figure includes 1,659,000 kg CO2e from Scope 1 emissions and 2,563,000 kg CO2e from Scope 2 emissions. Notably, the company has not disclosed any Scope 3 emissions data. Guardant Health has set ambitious near-term targets to significantly reduce its carbon footprint. The company aims to reduce its Scope 1 emissions to near zero by 2025 and has committed to achieving a similar reduction for its Scope 2 emissions within the same timeframe. These commitments reflect a proactive approach to climate responsibility within the pharmaceuticals, biotechnology, and life sciences sector. As of now, Guardant Health has not committed to a net-zero target, but it is actively working towards substantial emissions reductions in the near term. The company's climate initiatives are not cascaded from any parent organisation, indicating that these targets and data are independently reported.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
1,659,000
Scope 2
2,563,000
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Guardant Health's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Guardant Health is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Guardant Health is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Illumina

US
•
Research and development services (73)
Updated 3 days ago

OPKO Health, Inc.

US
•
Other business services (74)
Updated about 1 month ago

GeneDx Holdings Corp.

US
•
Other business services (74)
Updated 25 days ago

Personalis

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Quest Diagnostics

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Exact Sciences

US
•
Research and development services (73)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy